Karl Mettinger, MD, PhD
Oncolytics Biotech
1
0
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Vivek Subbiah, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
E-mail: ClinicalTrials@ ImClone.com
Eli Lilly and Company
Shared therapeutic areas:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
AeRang Kim, MD, PhD
Children's National Research Institute
Shared therapeutic areas:
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Claudia Valverde
Hospital Universitari Vall d'Hebrón
Shared therapeutic areas:
Javier Martínez Trufero, MD
Hospital Miguel Servet
Shared therapeutic areas:
Sandra D'Angelo, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Roberto Díaz, MD
Hospital Universitario La Fe
Shared therapeutic areas:
Luís Miguel de Sande
Complejo Asistencial Universitario de León
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
All 1 trials loaded